IMPAX Laboratories, Inc. (OTC:IPXL) today announced that Arthur A. Koch, Jr., its senior vice president and chief financial officer, will present at the Citi Investment Research 2008 Global Healthcare Conference on Thursday, May 22nd, at 11:30 a.m. Eastern time. The conference will be held at the Hilton New York Hotel from May 21 to 22, 2008.
Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Companyâ€™s web site at www.impaxlabs.com. To listen to the live presentation, please go to the web site 15 minutes prior to its start to register, download, and install the necessary audio software. This presentation will be archived on the Companyâ€™s web site for 90 days. The Companyâ€™s regular Corporate presentation will be updated and posted on the Companyâ€™s web site on that date as well.
About IMPAX Laboratories, Inc.
IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and markets its branded products through the IMPAX Pharmaceuticals division. Additionally, where strategically appropriate, IMPAX has developed marketing partnerships to fully leverage its technology platform. IMPAX Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company’s Web site at: www.impaxlabs.com.
IMPAX Laboratories, Inc.
Larry Hsu, Ph.D. President & CEO, 510-476-2000, ext. 1111
Arthur A. Koch, Jr., Sr. VP & CFO, 215-933-0351
Mark Donohue, Sr. Director IR, 215-933-3526
Investor Relations Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, 212-838-3777
Bruce Voss, 310-691-7100